Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment
Clinical trial NCT07275216 · RECRUITING
Trial details
- NCT number
- NCT07275216
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2029-10-20
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.